In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art
S Snykers, J De Kock, V Rogiers, T Vanhaecke - Stem cells, 2009 - academic.oup.com
Stem cells are a unique source of self-renewing cells within the human body. Before the end
of the last millennium, adult stem cells, in contrast to their embryonic counterparts, were …
of the last millennium, adult stem cells, in contrast to their embryonic counterparts, were …
Serum‐free media for the production of human mesenchymal stromal cells: a review
S Gottipamula, MS Muttigi, U Kolkundkar… - Cell …, 2013 - Wiley Online Library
The regenerative potential of mesenchymal stromal cells (MSC) holds great promise in
using them for treatment of a wide range of debilitating diseases. Several types of culture …
using them for treatment of a wide range of debilitating diseases. Several types of culture …
Platelet-derived bio-products: classification update, applications, concerns and new perspectives
A Acebes-Huerta, T Arias-Fernández… - … and Apheresis Science, 2020 - Elsevier
Platelet derived bio-products in the form of platelet rich plasma, plasma rich in growth
factors, or plasma-free platelet releasates, are being studied worldwide with the aim of …
factors, or plasma-free platelet releasates, are being studied worldwide with the aim of …
Expansion of adipose tissue mesenchymal stromal progenitors in serum‐free medium supplemented with virally inactivated allogeneic human platelet lysate
DTB Shih, JC Chen, WY Chen, YP Kuo, CY Su… - …, 2011 - Wiley Online Library
BACKGROUND: Single‐donor or pooled platelet lysates (PL) can substitute for fetal bovine
serum (FBS) for mesenchymal stromal cell (MSC) expansion. However, for clinical …
serum (FBS) for mesenchymal stromal cell (MSC) expansion. However, for clinical …
Effect of Platelet‐Rich Plasma on CCl4‐Induced Chronic Liver Injury in Male Rats
Z Hesami, A Jamshidzadeh… - … journal of hepatology, 2014 - Wiley Online Library
Platelet‐rich plasma (PRP) has been of great concern to the scientists and doctors who are
involved in wound healing and regenerative medicine which focuses on repairing and …
involved in wound healing and regenerative medicine which focuses on repairing and …
Osteogenic differentiation of stem cells derived from menstrual blood versus bone marrow in the presence of human platelet releasate
S Darzi, AH Zarnani, M Jeddi-Tehrani… - … Engineering Part A, 2012 - liebertpub.com
In recent decades, stem cell therapy has been introduced as a novel therapeutic approach
for patients suffering from bone disorders. Recently, menstrual blood has been identified as …
for patients suffering from bone disorders. Recently, menstrual blood has been identified as …
[HTML][HTML] Biochemical and molecular mechanisms of platelet-rich plasma in ameliorating liver fibrosis induced by dimethylnitrosurea
Background/Aims: Hepatic fibrosis is a wound-healing process in the chronically injured
liver. Clinical application of platelet-rich plasma (PRP) is of considerable interest for wound …
liver. Clinical application of platelet-rich plasma (PRP) is of considerable interest for wound …
Comparative Evaluation of Differentiation Potential of Menstrual Blood- Versus Bone Marrow- Derived Stem Cells into Hepatocyte-Like Cells
Menstrual blood has been introduced as an easily accessible and refreshing stem cell
source with no ethical consideration. Although recent works have shown that menstrual …
source with no ethical consideration. Although recent works have shown that menstrual …
Comparative capability of menstrual blood versus bone marrow derived stem cells in neural differentiation
In order to characterize the potency of menstrual blood stem cells (MenSCs) for future cell
therapy of neurological disorders instead of bone marrow stem cells (BMSCs) as a well …
therapy of neurological disorders instead of bone marrow stem cells (BMSCs) as a well …
Liver cell therapy and tissue engineering for transplantation
JP Vacanti, KM Kulig - Seminars in pediatric surgery, 2014 - Elsevier
Liver transplantation remains the only definitive treatment for liver failure and is available to
only a tiny fraction of patients with end-stage liver diseases. Major limitations for the …
only a tiny fraction of patients with end-stage liver diseases. Major limitations for the …